Difference between revisions of "Team:UC Davis/Design"

Line 657: Line 657:
  
  
 
<!-- This is the back to top button -->
 
<td bgColor=#FFFFFF> </td>
 
</table>
 
</td>
 
<td bgColor="#FFFFFF"></td>
 
</table>
 
 
<a href="#menu" style="text-decoration:none" color="#FFFFFF" fillerwordsyeeeeeah</font><font color = "#6A181B" font size="11">&nbsp; &nbsp; &nbsp; &nbsp; &#x21a5;</font></a>
 
<!-- END OF BLOCK -->
 
 
 
 
!------------- WL5------------->
 
<table  id="WL5" width="100%"  cellspacing="0" height="200px">
 
<tr><td  bgColor="#FFFFFF"></td>
 
<td width="975px" align="top" bgColor="#FFFFFF" > <!-- alignment of text-->
 
 
 
Environmental and health impact of Triclosan:<br>
 
<b>Wastewater and the Environment: </b><br>
 
Triclosan has been marketed as an antimicrobial agent that adds value to various hygiene and other consumer products[Perencevich, 2001]. Unfortunately, its increased prevalence in a variety of products means that increasing amounts are ending up down the drains, into the wastewater treatment plants[Shelver, 2007; Tatarazako, 2004; Dann, 2011] and ultimately into the environment. While some Triclosan gets removed in the water treatment process significant amounts still make it out into the environment when biosolids from the wastewater treatment process are used as crop fertilizers[Sabaliunas, 2003; Bock, 2010]. Once in the environment triclosan is very good at killing certain types of algae [Tatarazako, 2004].  Since environmental algae are primary producers, decreases in their abundance lead to subsequent decreases in the zooplankton that feed on the algae; in so doing propagate the effects of triclosan further up the food web. At very high concentrations, this could have a dramatic effect on the trophic balance of the ecosystems we all depend on. At more dilute concentrations, we might expect to see long-term rebalancing of trophic levels and in ways that are difficult to predict and whose significance to human health are unknown.  <br><br>
 
 
<b>Human and Animal Effects:</b><br>
 
Triclosan has also been shown to bioaccumulate in animals and have serious effects on their hormones during development[Fair, 2009; Raut, 2009]. It has been shown to get absorbed into the human body through the salivary glands and exits through the urinary tract [Calafat, 2008].  In addition, triclosan has been shown to be an endocrine disruptor[Crofton, 2007; Zorrilla, 2009; Paul, 2010; Raut, 2009; Stoker, 2010]. Some animal studies have shown that triclosan alters important hormone levels, which could result in neurotoxicity, decreased thyroid function and the growth of breast cancer cells[Gee, 2008; James, 2010; Fair, 2009]. Finally, triclosan has been found in 97% of american mothers’ breast milk and fetal cord blood; while its health effects are not completely known this observation that together with its known influence on important cell signalling pathways raises further questions about why it is used so prevalently[Allymyr, 2006; Adolfsson-Erici, 2002; Peters, 2005]. <br><br>
 
 
<b>Antimicrobial resistance:</b><br>
 
The use of antimicrobial compounds has accelerated rapidly across a wide variety of sectors (from healthcare to agriculture to consumer goods) since the discovery of penicillin in 1928 [Ligon, 2004]. However, the overuse of antimicrobials has been starting to show its negative effects. For example, bacteria resistant to antibiotics is directly responsible for 15 times as many deaths in Europe every year than AIDS[González-Zorn, 2012].  In the case of triclosan, certain resistant strains of Staphylococcus aureus have already been discovered[Suller, 2000; Fan, 2002].  This is quite alarming since resistance seems to be due to a single point mutation.  Given the seemingly low evolutionary barrier for resistance to triclosan, it’s beneficial use in hospital settings, and its ever growing environmental footprint, it seems that concern over its seemingly unregulated use is warranted[Shelver, 2007; Tatarazako, 2004; Dann, 2011].  While the concentrations used in consumer products is too high to select for resistance in the products themselves, the residues from the cosmetics and other products left on countertops may have the right concentrations needed for resistance selection[Levy, 2002; Yazdankhah, 2006]. <br><br>
 
 
While antimicrobials have always been present in the natural environment - they are ways that plants and fungi naturally defend themselves from invading bacterium[González-Zorn, 2012] - human exploitation of these natural resources and overuse are causing a decrease in their efficacy. Through public awareness, control and proper human practice, the use of antimicrobials like triclosan can be decreased help minimize their impact on the environment and to help maintain their efficacy in the places their use is warranted. <br><br>
 
 
<b>References:</b><br>
 
Perencevich EN, Wong MT, Harris AD. National and regional assessment if the antibacterial soap  market: a step toward determining the impact of prevalent antibacterial soaps. American Journal of Infection Control. 2001 Oct; 29(5):281-283. <br><br>
 
 
Allymyr M, Adolfsson-Erici M, McLachlan MS, Sandborgh-Englund G. Triclosan in Plasma and Milk from Swedish Nursing Mothers and Their Exposure Via Personal Care Products. Science of the Total Environment. 2006; 372(1) 87-93.<br><br>
 
 
Adolfsson-Erici M, Pettersson M, Parkkonen J, Sturve J. 2002. Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere. 2002; 46: 1485-1489. <br><br>
 
 
Peters RJB. Man-made chemicals in maternal and cord blood. TNO Built Environment and Geosciences-Report. 2005. <br><br>
 
 
Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Urinary Concentrations of Triclosan in the U.S. Population: 2003-2004. Environmental Health Perspectives. 2008; 116(3), 303-07. <br><br>
 
 
Centers for Disease Control. Fourth National Report on Human Exposure to Environmental Chemicals. 2009. 38-20. <br><br>
 
 
Wilding B, Curtis K, Welker-Hood K. Hazardous chemicals in health care: a snapshot of chemicals in doctors and nurses. Physicians for Social Responsibility. 2009 Oct.RN <br><br>
 
 
Fair PA, Lee HB, Adams J, Darling C, Pacepavicius G, Alaee M, Bossart GD, Henry N, Muir D. Occurrence of triclosan in plasma of wild Atlantic bottlenose dolphins (tursops truncates) and in their environment. Environmental Pollution. 2009 Aug-Sept; 157(8-9): 2248-54.  <br><br>
 
 
Ahn KC, Zhao B, Chen J. In vitro biological activities of the antimicrobial triclocarban, its analogues, and triclosan in bioassay screens: receptor-based bioassay screens. Environmental Health Perspectives. 2008 May.  <br><br>
 
 
Crofton KM, Paul KB, DeVito MJ, Hedge JM. Short-term in vivo exposure to the water contaminant triclosan: evidence for disruption of thyroxine. Environmental Toxicology and Pharmacology. 2007; 24: 194-197.  <br><br>
 
 
Gee RH, Charles A, Taylor N, Darbre PD. Oestrogenic and androgenic activity of triclosan in breast cancer cells. Journal of Applied Technology. 2008: 38: 78-91.  <br><br>
 
 
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocrine Reviews. 2009 June; 30(4): 293–342.  <br><br>
 
 
Zorrilla LM, Gibson EK, Jeffay SC, Crofton KM, Setzer WR, Cooper RL, Stoker TE. The effects of triclosan in puberty and thyroid hormones in male wistar rats. Toxicological Sciences. 2009 Jan; 107(1): 56-64.  <br><br>
 
 
Paul KB, Hedge JM, DeVito MJ, Crofton KM. Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in you long-evans rats. Toxicological Sciences. 2010 Feb; 113(2): 367-79.  <br><br>
 
 
Kumar V, Chakraborty A, Kural M, Roy P. Alteration of testicular steroidogenesis and histopathology of reproductive system in male rats treated with triclosan. Reproductive Toxicology. 2009 April; 27(2): 177-185.  <br><br>
 
 
Raut SA, Angus RA. Triclosan has endocrine-disrupting effects in male western mosquitofish, gambusia affinis. Environmental Toxicology and Chemistry. 2009 Dec; 29(6): 1287-1291.  <br><br>
 
 
Stoker TE, Gibson EK, Zorrilla LM. Triclosan exposure modulates estrogen-dependent Responses in the female wistar rat. Toxicological Sciences. 2010 June; 117(1): 45-53.  <br><br>
 
 
James MO, et al. Triclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta. Environment International. 2010 Nov; 36(8): 942-9. <br><br>
 
 
Dhillon GS, Kaur S, Pulicharla R, et al. Triclosan: Current Status, Occurrence, Environmental Risks and Bioaccumulation Potential. Tchounwou PB, ed.International Journal of Environmental Research and Public Health. 2015;12(5):5657-5684. doi:10.3390/ijerph120505657. <br><br>
 
 
Sabaliunas D., Webb S.F., Hauk A., Jacob M., Eckhoff W.S. Environmental fate of triclosan in the River Aire Basin, UK. Water Res. 2003;37:3145–3154. doi: 10.1016/S0043-1354(03)00164-7. <br><br>
 
 
Bock M., Lyndall J., Barber T., Fuchsman P., Perruchon E., Capdevielle M. Probabilistic application of a fugacity model to predict triclosan fate during wastewater treatment. Integr. Environ. Assess Manag.2010;6:393–404. doi: 10.1897/IEAM_2009-070.1.  <br><br>
 
 
González-Zorn, B., & Escudero, J. A. (2012). Ecology of antimicrobial resistance: humans, animals, food and environment. International Microbiology,15(3), 101-109. <br><br>
 
 
Fernando, D. M., Xu, W., Loewen, P. C., Zhanel, G. G., & Kumar, A. (2014). Triclosan can select for an AdeIJK-overexpressing mutant of Acinetobacter baumannii ATCC 17978 that displays reduced susceptibility to multiple antibiotics. Antimicrobial agents and chemotherapy, 58(11), 6424-6431. <br><br>
 
 
Ligon, B. L. (2004, January). Penicillin: its discovery and early development. InSeminars in pediatric infectious diseases (Vol. 15, No. 1, pp. 52-57). WB Saunders.  <br><br>
 
 
Suller, M. T. E., & Russell, A. D. (2000). Triclosan and antibiotic resistance in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 46(1), 11-18. <br><br>
 
 
Fan, F., Yan, K., Wallis, N. G., Reed, S., Moore, T. D., Rittenhouse, S. F., ... & Payne, D. J. (2002). Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicrobial agents and chemotherapy, 46(11), 3343-3347. <br><br>
 
 
Levy, S. B. (2002). Antimicrobial consumer products: where's the benefit? What's the risk?. Archives of Dermatology, 138(8), 1087-1088. <br><br>
 
 
Yazdankhah, S. P., Scheie, A. A., Høiby, E. A., Lunestad, B. T., Heir, E., Fotland, T. Ø., ... & Kruse, H. (2006). Triclosan and antimicrobial resistance in bacteria: an overview. Microbial drug resistance, 12(2), 83-90. <br><br>
 
 
Shelver, W. L., Kamp, L. M., Church, J. L., & Rubio, F. M. (2007). Measurement of triclosan in water using a magnetic particle enzyme immunoassay. Journal of agricultural and food chemistry, 55(10), 3758-3763. <br><br>
 
 
Tatarazako, N., Ishibashi, H., Teshima, K., Kishi, K., & Arizono, K. (2004). Effects of triclosan on various aquatic organisms. Environmental sciences: an international journal of environmental physiology and toxicology, (11), 133-40. <br><br>
 
 
Dann, A. B., & Hontela, A. (2011). Triclosan: environmental exposure, toxicity and mechanisms of action. Journal of Applied Toxicology, 31(4), 285. <br><br>
 
  
 
<!-- This is the back to top button -->
 
<!-- This is the back to top button -->

Revision as of 00:21, 21 December 2015

        ↥


We calculated the cost to run the enzyme assay using the native substrate analog crotonyl-CoA, and calculated it costs 67 cents. A report published in 2002 by the American Association of Physics Teachers recommended that the budget for high school laboratories to be $1 per student per week[20]. Assuming this is the recommended budget for other laboratory courses, students would be unable to run our assay more than once in a given week. We calculated the cost of our enzyme assay:
and found that 89% of the cost actually came from crotonyl CoA. In addition to being expensive, Coenzyme A (CoA) is not very stable in solution. Sigma has reported that solutions stored at -20C are only stable for 2 weeks! [21]

In order to implement our device in a high school laboratory setting, we wanted our assay to be under 10 cents to run. This would allow a student to run our assay ~ 10 times. We couldn’t change the cost to produce the enzyme, nor its cofactor NADH, but it seemed feasible to try to find a cheaper substrate to use that did not involve CoA. Just like our enzyme screening process above, we needed to understand the chemistry behind how crotonyl CoA reacted in order to find cheaper substrates to use. We knew the reaction involved the reduction of the C2-C3 double bond. Rafferty et al first proposed the mechanism in which a hydride from NADH transferred to C3, which formed an enolate anion on the carbonyl oxygen. A proton transfer from tyrosine then leads to a keto-enol tautomerization [25][26]. In vivo, crotonyl is covalently bonded to acyl carrier protein, but coenzyme A is used as an analog. The purpose of these two molecules is to carry acyl chains through the cytoplasm (Acyl refers to CH3-C=O groups) [27].



We therefore designed a chemical biology screening based on two parameters: functional group similarity to the crotonyl moiety and to mimic CoA’s role as an acyl carrier. We wanted to explore a large chemical space to increase our chances of finding a hit. We weren’t completely sure if FabI only reduced carbon-carbon double bonds, so we tested valeraldehyde to see if FabI could reduce the aldehyde to an alcohol. To see if FabI could reduce the C-C double bond of an unsaturated carboxylic acid, we tested crotonic acid. We then tested three unsaturated aldehydes, just like crotonyl-CoA, but without the CoA moiety. And finally, to try and find potential acyl carriers, we tested bulky substrates with rings (phenyl acetaldehyde, p-anisaldehyde, and 3-(5-methyl-2-furyl)butanal).









We discovered enzyme activity on the three unsaturated aldehydes (trans-2-pentenal, 2-ethyl-2-butenal, and trans,trans-2,4-heptadienal), but had no activity on any of the other substrates!


We found the enzymes were most active on trans-2-pentenal. There was no measurable enzyme activity using the other 5 substrates. This is highly consistent with the enzyme mechanism in which an allylic double bond is reduced when adjacent to an activating group, such as an electrophilic carbonyl (e.g. an aldehyde or thioester). Furthermore, crotonic acid has a less electrophilic group adjacent to the allylic double bond, highlighting the high selectivity of FabI for the electronic structure of its substrates.

While significant activity is observed on these alternative substrates, there was a decrease in overall enzyme activity relative to the near-native Crotonyl CoA substrate of ~100-fold. This made it so >500nM enzyme is needed to see enzyme activity in assays. In order to be used to detect relevant levels of TCS in wastewater the enzyme must have measurable activity at concentrations lower than the concentrations of triclosan in wastewater ( up to 9nM). Therefore, we have begun to explore the use of enzyme engineering to enhance activity on trans-2-pentenal!



Continue scrolling to read more or click here to advance to the next section!

        ↥


Fortunately a crystal structure for the P. falciparum FabI enzyme had already been determined[28]. We used the computational tool Foldit (See 1, 2, 3 ) to design 28 mutants. We hypothesized the trans-2-pentenal would occupy a highly similar structural space as triclosan. Analysis of triclosan bound to NADH in the active site revealed that the phenyl ring of triclosan lined up face to face with the ring of NADH forming a pi-stacking interaction. We hypothesized that if we could increase the pi-stacking interaction by mutating residues around the triclosan-NADH site to be aromatic residues, we might be able to increase the enzyme’s activity on trans-2-pentenal.

Each mutant was generated using kunkel mutagenesis through the transcriptic cloud laboratory. The sequence verified mutant genes were cloned into our expression strain of E. coli and protein produced and purified as described in our Notebook [LINK]. From this initial round of 28 mutants, 23 expressed as soluble protein. Of the solubly expressed designs 4 of the designs had no effect on function, and 19 decreased activity. However, one of the enzymes resulted in 1.5x increase in activity against the non-natural trans-2-pentenal substrate.

We are currently exploring new mutants based on the data generated from this first round of screens. While the enzyme activity needs to be improved ~100-fold in order to achieve levels of activity observed on the native substrate, this is well within reach of enzyme engineering efforts based on previous successes [30][31][32] Sources:
        ↥




In the lab we used an EPOCH spectrophotometer to run our assays. At a price tag of ~$10,000 this device is definitely out of the budget range of a high school teacher, so we looked for a more appropriately priced alternative.

We found a colorimeter device from IO Rodeo, a company that develops open source hardware and software for educational purposes. They sold a spectrophotometer which we hypothesized would work for our assay for $80. One reason for the price difference is the EPOCH is a monochronometer covers a spectrum from 200 nm - 999 nm, selectable in 1 nm increments. The IO Rodeo is based on an 365nm LED and requires hardware changes to adjust the wavelength of emission and detection. Our enzyme assay is based on oxidation of the enzyme cofactor NADH into NAD. The standard wavelength for detection of this reaction is 340nm, however the NADH has a broad spectrum (see figure below). Based on the differences in NAD and NADH spectral signals we hypothesized that the 365nm LED should provide a sufficient signal to detect the NADH to NAD conversion.



We purchased the IO Rodeo spectrophotometer and compared NADH sensitivity on the IO Rodeo spectrophotometer and EPOCH spectrophotometer.

Test #1: NADH Sensitivities We first compared the linear ranges of the devices and found that there was a linear relationship between NADH concentration and absorbance between 6 micro molar and 400 micro molar for both devices. This means that both instruments had the required sensitivity for our assay under ideal conditions:



Protocol for colorimeter test #1:
All test solutions were prepared from a single freshly made 0.5 mM NADH stock solution. Each test solution was measured in triplicate on both the IO Rodeo colorimeter and the EPOCH spectrophotometer.

Test #2: FabI Inhibition Assays (i.e. functional prototype) In order to illustrate the utility of a device that meets our design requirements. We then tested to see if the IO Rodeo device could be used for an inhibition assay. As illustrated in Figure below the NADH oxidation rate is significantly lower in the presence of nM triclosan levels than in the absence of triclosan. The IO rodeo portable spectrophotometer is also able to detect various levels of triclosan inhibition...right out of the box!



This assay used triplicates of 2 nM P. falciparum FabI. 100 uM crotonyl-CoA, 100 uM NADH

We are now working in refining the assay to measure and improve robustness (accuracy when tested by multiple users), specificity (substrate and alternative inhibitors), and sensitivity (more detailed inhibition curves and optimization of conditions). We will also be working with high school students to see if the assay can be used successfully in high schools.
        ↥
Can we detect enzyme inhibition in waste water?

In order for our show we had a functional prototype, we needed to show enzyme inhibition in waste water. We performed this experiment using triplicates of 15 nM P. falciparum FabI. It appears as if life is a bit slower in waste water…



This shows that our biosensor works in waste water!

        ↥


  • Confirm inhibition data in waste water correlates to known levels of triclosan in a wide variety of waste water samples
  • Continue rounds of enzyme engineering to enhance another 60-fold (~10 more 1.5 folds… or 1 60-fold)
  • Forward predictions based on unknown samples where the biosensor, ELISA, and MS are used in parallel





Sources:
[1] J, Regös, Zak O, Solf R, Vischer WA, and Weirich EG. "Antimicrobial Spectrum of Triclosan, a Broad-spectrum Antimicrobial Agent for Topical Application. II. Comparison with Some Other Antimicrobial Agents." National Center for Biotechnology Information. U.S. National Library of Medicine, 1979.
[2] Kini, Suvarna, Anilchandra R. Bhat, Byron Bryant, John S. Williamson, and Franck E. Dayan. "Synthesis, Antitubercular Activity and Docking Study of Novel Cyclic Azole Substituted Diphenyl Ether Derivatives." EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. N.p., May 2008.
[3] McMurry, Laura M., Margret Oethinger, and Stuart B. Levy. "Triclosan Targets Lipid Synthesis." Nature 394 (1998): 531-32.
[4] Heath, R. J. , Yu, Y.-T. , Shapiro, M. A. , Olson, E. & Rock, C. O. J. Biol. Chem. 273, 30316–30320 (1998)
[5] RP, Massengo-Tiassé, and Cronan JE. "Diversity in Enoyl-acyl Carrier Protein Reductases." Cell Mol Life Sci. (May 2009)
[6] RJ, Heath, Rubin JR, Holland DR, Zhang E, Snow ME, and Rock CO. "Mechanism of Triclosan Inhibition of Bacterial Fatty Acid Synthesis." J Biol Chem (April 1999)
[7] Ward, Walter. "Kinetic and Structural Characteristics of the Inhibition of Enoyl (acyl Carrier Protein) Reductase by Triclosan." Biochemistry (1999 Sep 21)
[8] Kapoor, Mili. "Slow-tight-binding Inhibition of Enoyl-acyl Carrier Protein Reductase from Plasmodium Falciparum by Triclosan." Biochem (2004 August 1)
[9] Surolia, Namita, and Avadhesha Surolia. "Triclosan Offers Protection against Blood Stages of Malaria by Inhibiting Enoyl-ACP Reductase of Plasmodium Falciparum." Nature Medicine (2001)
[10] Marcinkeviciene, J.et al, (2001). "Enoyl-ACP Reductase (FabI) of Haemophilus influenzae: Steady-State Kinetic Mechanism and Inhibition by Triclosan and Hexachlorophene." Archives of Biochemistry and Biophysics 390(1): 101-108.
[11] Courtney Slater-Radosti, Glenn Van Aller, Rebecca Greenwood, Richard Nicholas, Paul M. Keller, Walter E. DeWolf, Jr, Frank Fan, David J. Payne, and Deborah D. Jaworski Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus J. Antimicrob. Chemother. (2001) 48 (1): 1-6. doi: 10.1093/jac/48.1.1
[12] Mechanism and Inhibition of saFabI, the Enoyl Reductase from Staphylococcus aureus Hua Xu, Todd J. Sullivan, Jun-ichiro Sekiguchi, Teruo Kirikae, Iwao Ojima, Christopher F. Stratton, Weimin Mao, Fernando L. Rock, M. R. K. Alley, Francis Johnson, Stephen G. Walker and Peter J. Tonge Institute for Chemical Biology & Drug Discovery, Department of Chemistry, Stony Brook University, Stony Brook, New York 11794-3400, School of Dental Medicine, Stony Brook University, Stony Brook, New York 11794, Department of Infectious Diseases, International Medical Center of Japan, Tokyo 162-8655, Japan, and Discovery Biology, Anacor Pharmaceuticals Inc., Palo Alto, California 94303
[13] Hoang TT, Schweizer HP. 1999. Characterization of Pseudomonas aeruginosaenoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J. Bacteriol.181:5489–5497.
[14] Parikh, S. L., Xiao, G. and Tonge, P. J. (2000) ‘Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid’,Biochemistry, Vol. 39, No. 26, pp.7645-7650.
[15] Massengo-Tiassé, R. P., and J. E. Cronan. 2009. Diversity in enoyl-acyl carrier protein reductases. Cell. Mol. Life Sci.66:1507–1517.
[16] Dayan FE, Ferreira D, Wang YH, Khan IA, McInroy JA, Pan Z
(2008) A pathogenic fungi diphenyl ether phytotoxin targets plant enoyl (acyl carrier protein) reductase. Plant Physiol 147: 1062–1071
[17] Liu N, Cummings JE, England K, Slayden RA, Tonge PJ. 2011. Mechanism and inhibition of the FabI enoyl-ACP reductase from Burkholderia pseudomallei. J. Antimicrob. Chemother. 66:564–573. 10.1093/jac/dkq509
[18] Chalew T. E., Halden R. U. (2009). Environmental exposure of aquatic and terrestrial biota to triclosan and triclocarban. J. Am. Water Works Assoc. 45, 4–13. 10.1111/j.1752-1688.2008.00284.x
[19] Eriksson M, Johansson H, Fihlman V, Grehn A, Sanli K, Andersson MX, Blanck H, Arrhenius Å, Sircar T, Backhaus T. (2014) Long-term effects of the antibacterial agent triclosan on marine periphyton communities. PeerJ PrePrints 2:e489v1 [20] "Guidelines for High School Physics Programs." HS Guidelines.
[21] Corp., Sigma-Aldrich. Acetyl Coenzyme A Trilithium Salt (A2181) - Product Information Sheet (n.d.): n. pag. Sigma.
[22] Vick JE, Clomburg JM, Blankschien MD, Chou A, Kim S, Gonzalez R.Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle. Vol. 269, No. 8,Issue of February 25, pp. 5493-5496, 1994 The Journal of Biological Chemistry, 269, 5493-5496.
[23]. Pidugu, L. S., M. Kapoor, N. Surolia, A. Surolia and K. Suguna (2004). "Structural basis for the variation in triclosan affinity to enoyl reductases." J Mol Biol 343(1): 147-155.
[24] Links to purchase NADPH and NADH: https://www.fishersci.com/shop/products/nadph-tetrasodium-salt-hydrate-96-extra-pure-acros-organics-2/p-171261, https://www.fishersci.com/shop/products/beta-nicotinamide-adenine-dinucleotide-disod-salt-hydrate-95-reduced-form-acros-organics-4/p-3737061
[25] White, S. W., J. Zheng, Y. M. Zhang and Rock (2005). "The structural biology of type II fatty acid biosynthesis." Annu Rev Biochem 74: 791-831.
[26] Rafferty, J. B., J. W. Simon, C. Baldock, P. J. Artymiuk, P. J. Baker, A. R. Stuitje, A. R. Slabas and D. W. Rice (1995). "Common themes in redox chemistry emerge from the X-ray structure of oilseed rape (Brassica napus) enoyl acyl carrier protein reductase." Structure 3(9): 927-938.
[27] Elovson, J. and P. R. Vagelos (1968). "Acyl Carrier Protein: X. ACYL CARRIER PROTEIN SYNTHETASE." Journal of Biological Chemistry 243(13): 3603-3611.
[28] Perozzo, R., M. Kuo, A. Sidhu, J. T. Valiyaveettil, R. Bittman, W. R. Jacobs, Jr., D. A. Fidock and J. C. Sacchettini (2002). "Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase." J Biol Chem 277(15): 13106-13114.
[29] Johansson, C. H., L. Janmar and T. Backhaus (2014). "Triclosan causes toxic effects to algae in marine biofilms, but does not inhibit the metabolic activity of marine biofilm bacteria." Mar Pollut Bull 84(1-2): 208-212.
[30] Savile, C. K., J. M. Janey, E. C. Mundorff, J. C. Moore, S. Tam, W. R. Jarvis, J. C. Colbeck, A. Krebber, F. J. Fleitz, J. Brands, P. N. Devine, G. W. Huisman, and G. J. Hughes. "Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture." Science 329.5989 (2010): 305-09.
[31] J. B. Siegel et al., Science 329, 309 (2010)
[32] Bornscheuer, U. T., G. W. Huisman, R. J. Kazlauskas, S. Lutz, J. C. Moore and K. Robins (2012). "Engineering the third wave of biocatalysis." Nature 485(7397): 185-194.
        ↥



Design:

When we first started our project, we took a trip to our local Safeway to catalog products containing triclosan. We discovered that many products had already phased out triclosan; some labels even read “Triclosan Free.” Although triclosan had been removed from products, many of them had simply replaced it with a different antimicrobial.

This trend reminded us of what Arlene Blum told us about how when chemicals are removed from use manufacturers look for a replacement; but because these chemicals need to serve similar functions they often have similar structures, and thus similar consequences. What results is a cycle whereby one toxic chemical is replaced by another toxic chemical.

We didn’t want to raise fear over triclosan use and contribute to this cycle. Instead we wanted to raise awareness around appropriate chemical use and reduce the use of chemicals in cases where there is no proven benefit.

This lead us to supplementing our triclosan biosensor with an, “antimicrobial footprint app,” to get consumers thinking about whether antimicrobial agents are even warranted in consumer products.



Deliverable:

We designed our app as a heuristic to raise awareness about the unnecessary ubiquity of antimicrobials in consumer products. In the app, the user can click on an “About” tab to learn more about antimicrobials and how to be a responsible consumer. They can then go on to calculate their “Antimicrobial Footprint.” The user is able to click on antimicrobial containing products that they use, and see how it affects their total footprint. After using the app’s antimicrobial calculator to calculate their footprint, the user can submit their footprint along with their location. On the final page of the app the user is able to see how their footprint compares to the average footprint of other users. The submitted data is used to calculate this average, as well as to create a heat map of antimicrobial usage in the United States. This is another deliverable that users can look at to become more educated consumers.


space space space space



How it Works:

To create the antimicrobial calculator we found data on the levels of triclosan in selected consumer products, given in g triclosan/g products. We also found data on the daily use rates of consumer products, given in g triclosan/day. By combining this information we were able to calculate the users’ “antimicrobial footprint,” in grams triclosan/day. The app will also give you this metric in grams triclosan/year.

space space space

Sources:

Rodricks, Joseph V. "Triclosan: A Critical Review of the Experimental Data and Development of Margins of Safety for Consumer Products." Critical Reviews in Toxicology, 2010. Web.



        ↥